deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02887703

Augmenting Balance in Individuals With Cerebellar Ataxias

Sponsor: Kathleen Sienko

Updated 8 times since 2017 Last updated: Mar 6, 2018 Started: Sep 30, 2016 Primary completion: Jan 31, 2018 Completion: Jan 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02887703, this NA trial focuses on Cerebellar Ataxia and remains completed. Sponsored by Kathleen Sienko, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Nov 2017 · 9 months · monthly snapshotRecruiting~Nov 2017 – ~Mar 2018 · 4 months · monthly snapshotActive Not Recruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Mar 2018 — Jun 2018 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

Show 3 earlier versions
  1. Nov 2017 — Mar 2018 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  2. Feb 2017 — Nov 2017 [monthly]

    Recruiting NA

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kathleen Sienko
Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations